Literature DB >> 20519230

A systematic review of ethnic differences in the rate of renal progression in CKD patients.

Sean J Barbour, Michael Schachter, Lee Er, Ognjenka Djurdjev, Adeera Levin.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20519230     DOI： 10.1093/ndt/gfq283

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  15 in total

1.  APOL1 risk variants, race, and progression of chronic kidney disease.

Authors:  Afshin Parsa; W H Linda Kao; Dawei Xie; Brad C Astor; Man Li; Chi-yuan Hsu; Harold I Feldman; Rulan S Parekh; John W Kusek; Tom H Greene; Jeffrey C Fink; Amanda H Anderson; Michael J Choi; Jackson T Wright; James P Lash; Barry I Freedman; Akinlolu Ojo; Cheryl A Winkler; Dominic S Raj; Jeffrey B Kopp; Jiang He; Nancy G Jensvold; Kaixiang Tao; Michael S Lipkowitz; Lawrence J Appel
Journal:  N Engl J Med       Date:  2013-11-09       Impact factor: 91.245

2.  End stage renal disease risk and neighbourhood deprivation: a nationwide cohort study in Sweden.

Authors:  Delshad Saleh Akrawi; Xinjun Li; Jan Sundquist; Kristina Sundquist; Bengt Zöller
Journal:  Eur J Intern Med       Date:  2014-10-05       Impact factor: 4.487

3.  Serum 6-Bromotryptophan Levels Identified as a Risk Factor for CKD Progression.

Authors:  Adrienne Tin; Girish Nadkarni; Anne M Evans; Cheryl A Winkler; Erwin Bottinger; Casey M Rebholz; Mark J Sarnak; Lesley A Inker; Andrew S Levey; Michael S Lipkowitz; Lawrence J Appel; Dan E Arking; Josef Coresh; Morgan E Grams
Journal:  J Am Soc Nephrol       Date:  2018-05-18       Impact factor: 10.121

4.  Differences in progression to ESRD between black and white patients receiving predialysis care in a universal health care system.

Authors:  Tessa O van den Beukel; Moniek C M de Goeij; Friedo W Dekker; Carl E H Siegert; Nynke Halbesma
Journal:  Clin J Am Soc Nephrol       Date:  2013-07-11       Impact factor: 8.237

5.  Progression of Kidney Disease in Indigenous Australians: The eGFR Follow-up Study.

Authors:  Louise J Maple-Brown; Jaquelyne T Hughes; Rebecca Ritte; Federica Barzi; Wendy E Hoy; Paul D Lawton; Graham R D Jones; Elizabeth Death; Alison Simmonds; Ashim K Sinha; Sajiv Cherian; Mark A B Thomas; Robyn McDermott; Alex D H Brown; Kerin O'Dea; George Jerums; Alan Cass; Richard J MacIsaac
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-13       Impact factor: 8.237

6.  Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin-angiotensin system blockade: a UK general practice-based cohort study.

Authors:  Morten Schmidt; Kathryn E Mansfield; Krishnan Bhaskaran; Dorothea Nitsch; Henrik Toft Sørensen; Liam Smeeth; Laurie A Tomlinson
Journal:  BMJ Open       Date:  2017-01-09       Impact factor: 2.692

7.  Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study.

Authors:  Morten Schmidt; Kathryn E Mansfield; Krishnan Bhaskaran; Dorothea Nitsch; Henrik Toft Sørensen; Liam Smeeth; Laurie A Tomlinson
Journal:  BMJ       Date:  2017-03-09

8.  Ethnic differences in the progression of chronic kidney disease and risk of death in a UK diabetic population: an observational cohort study.

Authors:  Rohini Mathur; Gavin Dreyer; Magdi M Yaqoob; Sally A Hull
Journal:  BMJ Open       Date:  2018-03-27       Impact factor: 2.692

9.  Ethnicity matching and outcomes after kidney transplantation in the United Kingdom.

Authors:  Bhavini Pisavadia; Adam Arshad; Imogen Chappelow; Peter Nightingale; Benjamin Anderson; Jay Nath; Adnan Sharif
Journal:  PLoS One       Date:  2018-04-13       Impact factor: 3.240

10.  Does a medical management program for CKD patients postpone renal replacement therapy and mortality? A 5-year-cohort study.

Authors:  Mitra Mahdavi-Mazdeh; Zinat Nadia Hatmi; Sara Shahpari-Niri
Journal:  BMC Nephrol       Date:  2012-10-22       Impact factor: 2.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.